Lindbrook Capital, LLC - PDS BIOTECHNOLOGY CORP ownership

PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 66 filers reported holding PDS BIOTECHNOLOGY CORP in Q4 2021. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of PDS BIOTECHNOLOGY CORP
ValueSharesWeighting
Q3 2023$2,525
+0.4%
5000.0%0.00%
Q2 2023$2,515
-18.2%
5000.0%0.00%
Q1 2023$3,075
-53.4%
5000.0%0.00%
-100.0%
Q4 2022$6,600
+560.0%
5000.0%0.00%
Q3 2022$1,000
-50.0%
5000.0%0.00%
Q2 2022$2,000
-33.3%
5000.0%0.00%
Q1 2022$3,000
-25.0%
5000.0%0.00%
-100.0%
Q4 2021$4,0005000.00%
Other shareholders
PDS BIOTECHNOLOGY CORP shareholders Q4 2021
NameSharesValueWeighting ↓
INSPIRION WEALTH ADVISORS, LLC 330,874$1,670,9140.33%
TANG CAPITAL MANAGEMENT LLC 400,000$2,020,0000.28%
AMUSSEN HUNSAKER ASSOCIATES LLC 75,016$377,3300.08%
Nebula Research & Development LLC 25,708$129,8250.07%
Corton Capital Inc. 22,091$111,5600.06%
Sofinnova Investments, Inc. 142,635$720,3070.04%
LAZARI CAPITAL MANAGEMENT, INC. 11,000$55,5500.03%
OCCUDO QUANTITATIVE STRATEGIES LP 24,369$123,0630.02%
WINTON GROUP Ltd 21,256$107,3430.01%
Truvestments Capital LLC 1,372$6,9290.00%
View complete list of PDS BIOTECHNOLOGY CORP shareholders